“We are very pleased to announce these fourth quarter 2023 preliminary results, which is our highest quarterly revenue ever and continues our string of ten consecutive quarters of record revenues. The value of our products continues to resonate with our customers as we see growing demand for our products and expect this to continue through 2024,” said Roger Susi, President and Chief Executive Officer of the Company.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IRMD:
- IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
- IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
- iRadimed declares special dividend of 48c, initiates quarterly dividend
- iRadimed management to meet with Lake Street
